O'Connor Ellen Vos's Insider Trades & SAST Disclosures
O'Connor Ellen Vos's most recent trade in Modular Medical Inc was a trade of 7,500 Option to purchase common stock done . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern O'Connor Ellen Vos.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 13,286 | 62,774 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 10,061 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 10,061 | 49,488 (0%) | 0% | 0 | Common Stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| Modular Medical Inc | O'Connor Ellen Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 10,061 | 10,061 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,637 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,637 | 39,427 (0%) | 0% | 0 | Common Stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 657 | 34,790 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 657 | 657 | - | - | Restricted Stock Units | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 409 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 409 | 34,133 (0%) | 0% | 0 | Common Stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 7,500 | 7,500 | - | - | Option to purchase common stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 334 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 334 | 33,724 (0%) | 0% | 0 | Common Stock | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2022 | 1,648 | 1,648 | - | - | Option to purchase common stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 4,637 | 4,637 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 657 | 657 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 334 | 334 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 407 | 32,890 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 539 | 32,483 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 1,937 | 29,959 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Purchase of securities on an exchange or from another person at price $ 8.75 per share. | 31 Mar 2020 | 1,000 | 28,022 (0%) | 0% | 8.8 | 8,750 | Common Stock |
| OptimizeRx Corp | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2020 | 2,784 | 27,022 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges